Form 4: Celldex Therapeutics SVP, Chief Medical Officer, Diane C. Young, Reports Sale of 45,000 Shares
SEC Form 4 Filing
Diane C. Young, SVP, Chief Medical Officer of Celldex Therapeutics, Inc., reported the sale of 45,000 shares of common stock on June 7, 2024.
Summary
- On June 7, 2024, Diane C. Young, the SVP, Chief Medical Officer of Celldex Therapeutics, Inc., sold 45,000 shares of common stock.
- The shares were sold at a weighted average price of $35.2632.
- Following the transaction, Ms. Young directly owns 2,115 shares of Celldex Therapeutics, Inc.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting an insider stock sale. It doesn't inherently convey positive or negative sentiment, but the sale itself could be interpreted in various ways by investors.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings for insights into management's perspective on the company's stock.
Key Dates
| Date | Description |
|---|---|
| 06/07/2024 | Date of transaction: Sale of 45,000 shares of common stock. |
| 06/11/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.